4basebio PLC (4BB.L)
4basebio PLC, engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally.
525.00+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-45.9%
The outlook
4basebio PLC currently reads as neutral based on mixed vs its moving averages, 18% of the way from its 52-week low to high, avg target +205% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range18% of the way from its 52-week low to high
Price targetAvg target +205% vs current price
Analyst price target
~12-month · 2 analysts1,600.00average target+204.8% vs now
Now 525.00
Low 1,400.00High 1,800.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$81.3M
52-wk high
1,000.00
52-wk low
420.00
50-day avg
523.75
200-day avg
572.49
Trailing P/E
—